세계의 IOL 시장(2023년) : 2022-2028년 분석

What's New:

The "2023 IOL Market Report" examines the first-ever projected global decline in PC-IOL procedures and penetration in 2023-led by significantly reduced reimbursement in Japan and South Korea-and outlines the numerous countervailing positive and negative factors that will shape the IOL market over the next five years. One of these factors is refractive lens exchange, which has growing importance in driving premium IOL penetration.

SAMPLE VIEW

The report also thoroughly examines the RxSight post-op adjustable IOL, which has become the fastest growing IOL in the world (though from a small base) with sales only in the United States.

In addition, the report adds new analysis into factors shaping growing adoption of immediate sequential bilateral cataract surgery (ISBCS) and same-day/next day cataract surgery.

The "2023 IOL Market Report" provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.

This report describes and forecasts performance by region for 11 categories of IOLs: commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs. Additionally, 34 companies are profiled, with discussion of their products, strategic market position, background, and outlook.

Contents:

The "2023 IOL Market Report" offers a comprehensive look at the global IOL market, with eight regional/economic breakouts. The following information is included in this report:

• Information on cataract incidence and cataract surgeries worldwide.

• Current estimates and five-year forecasts for global cataract surgery volume.

• Forecasts for adoption of simultaneous bilateral cataract surgery.

• Discussion of presbyopia, refractive errors, and refractive lens exchange procedures.

• Forecasts for sales of five types of presbyopia-correcting IOLs (PC-IOLs) by country/region.

• Forecasts for sales of standard and toric versions of PC-IOLs.

• Forecasts for monovision and mini-monovision by country/region.

• Profiles of cataract and cataract/refractive surgeons in the US.

• Information on corporate surgery providers.

• Discussion of current reimbursement levels.

• Descriptions of new premium IOL technologies.

Author Profile:

William Freeman

Bill Freeman has more than 35 years of experience developing, manufacturing, and marketing cataract surgery products. He has held key executive positions at four firms that produce ophthalmic surgical devices.

Bill's career in ophthalmology began in the 1970s. As president of Cavitron Surgical Systems, he worked with Dr. Charles Kelman in developing and marketing the world's first phacoemulsifier system. While highly controversial in the 1970s, phacoemulsification gradually became the preferred cataract removal technique in the early 1980s. For many years, Cavitron led the cataract instrumentation market.

CooperVision purchased Cavitron in the early 1980s, and Bill joined the company as president of the surgical division. CooperVision expanded its product line to include a wide variety of cataract surgical products-IOLs, viscoelastic solutions, disposable devices, lasers, and custom packs-and became the market leader in many product categories.